Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine: A Real-World Study

• Published in: Hypertension (Dallas, Tex. 1979) Vol. 77; no. 2; pp. 461 - 471
• Main Authors: Dröge, Lisa Antonia, Perschel, Frank Holger, Stütz, Natalia, Gafron, Anna, Frank, Lisa, Busjahn, Andreas, Henrich, Wolfgang, Verlohren, Stefan
• Format: Journal Article
• Language: English
• Published: United States American Heart Association, Inc 01.02.2021
• Subjects: maternal death; blood pressure; pregnancy outcome; preeclampsia; HELLP syndrome

This retrospective real-world study investigated the clinical use of the sFlt-1 (soluble fms-like tyrosine kinase 1)/PlGF (placental growth factor) ratio alone or in combination with other clinical tests to predict an adverse maternal (maternal death, kidney failure, hemolysis elevated liver enzymes...